Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
S. Meers, D. Selleslag, H. Potier, A. Glasmacher, P. Mineur & V. Voelter. (2015) Azacitidine access program for Belgian patients with myelodysplastic syndromes, acute myeloid leukemia or chronic myelomonocytic leukemia. Current Medical Research and Opinion 31:1, pages 35-42.
Read now
Read now
Hind T. Hatoum, Swu-Jane Lin, Deborah Buchner & Edward Kim. (2011) Use of hypomethylating agents and associated care in patients with myelodysplastic syndromes: a claims database study. Current Medical Research and Opinion 27:6, pages 1255-1262.
Read now
Read now
Articles from other publishers (27)
Seokjin Ham, Sieun S. Kim, Sangsoon Park, Eun Ji E. Kim, Sujeong Kwon, Hae-Eun H. Park, Yoonji Jung & Seung-Jae V. Lee. (2022)
Systematic transcriptome analysis associated with physiological and chronological aging in
Caenorhabditis elegans
. Genome Research 32:11-12, pages 2003-2014.
Crossref
Crossref
M Maioli, S Rinaldi, S Cruciani, A Necas, V Fontani, G Corda, S Santaniello, A Rinaldi, AR Pinheiro Barcessat, A Necasova, A Castagna, Z Filipejova, C Ventura & C Fozza. (2022) Antisenescence Effect of REAC Biomodulation to Counteract the Evolution of Myelodysplastic Syndrome. Physiological Research 71:4, pages 539-549.
Crossref
Crossref
Mridu Singh, Vikram Singh, DurgaPrasad Singh, GopalKrishna Bohra & ArupKumar Misra. (2021) Hemorrhagic manifestation in different etiologies of pancytopenia: A prospective, cross-sectional study. Journal of Family Medicine and Primary Care 10:2, pages 804.
Crossref
Crossref
José María Bastida, Oriana López‐Godino, Ana Vicente‐Sánchez, Santiago Bonanad‐Boix, Blanca Xicoy‐Cirici, Jesus M. Hernández‐Sánchez, Esperanza Such, Jose Cervera, Juan C. Caballero‐Berrocal, Félix López‐Cadenas, Mario Arnao‐Herráiz, Inés Rodríguez, Inmaculada Llopis‐Calatayud, María J. Jiménez, Maria Consuelo Cañizo‐Roldán & Maria Díez‐Campelo. (2018)
Hidden myelodysplastic syndrome (MDS): A prospective study to confirm or exclude
MDS
in patients with anemia of uncertain etiology
. International Journal of Laboratory Hematology 41:1, pages 109-117.
Crossref
Crossref
Ronald Feitosa Pinheiro, Priscila Timbó Azevedo & Carolina Teixeira Costa. 2019. International Manual of Oncology Practice. International Manual of Oncology Practice
913
942
.
Srinivasan Narayanan. (2018) Managing anaemia in bone marrow failure syndromes. Current Opinion in Supportive & Palliative Care 12:4, pages 538-541.
Crossref
Crossref
Nages Nagaratnam, Kujan Nagaratnam & Gary CheukNages Nagaratnam, Kujan Nagaratnam & Gary Cheuk. 2018. Geriatric Diseases. Geriatric Diseases
239
242
.
R. Mahmoudi, J.-L. Novella & Y. Jaïdi. (2017) Transfusion des personnes âgées : tenir compte de la fragilité. Transfusion Clinique et Biologique 24:3, pages 200-208.
Crossref
Crossref
Joji Nagasaki, Yasutaka Aoyama, Masayuki Hino, Kentaro Ido, Hiroyoshi Ichihara, Masahiro Manabe, Tadanobu Ohta & Atsuko Mugitani. (2017) <b><i>Wilms Tumor 1 </i></b><b>(</b><b><i>WT1</i></b><b>)</b> mRNA Expression Level at Diagnosis Is a Significant Prognostic Marker in Elderly Patients with Myelodysplastic Syndrome. Acta Haematologica 137:1, pages 32-39.
Crossref
Crossref
Nages Nagaratnam, Kujan Nagaratnam & Gary CheukNages Nagaratnam, Kujan Nagaratnam & Gary Cheuk. 2017. Geriatric Diseases. Geriatric Diseases
1
4
.
Koji Hattori, Hiroaki Wada, Yuhei Makanae, Satoshi Fujita & Satoshi Konishi. (2016) RNA extraction from microtissues of skeletal muscle by a microfluidic shredding chip. IEEJ Transactions on Electrical and Electronic Engineering 11:S2.
Crossref
Crossref
Nages Nagaratnam, Kujan Nagaratnam & Gary CheukNages Nagaratnam, Kujan Nagaratnam & Gary Cheuk. 2016. Diseases in the Elderly. Diseases in the Elderly
95
116
.
Yan-Fung Wong, Chris N. Micklem, Masataka Taguchi, Hidehiro Itonaga, Yasushi Sawayama, Daisuke Imanishi, Shinichi Nishikawa, Yasushi Miyazaki & Lars Martin Jakt. (2014) Longitudinal Analysis of DNA Methylation in CD34+ Hematopoietic Progenitors in Myelodysplastic Syndrome. Stem Cells Translational Medicine 3:10, pages 1188-1198.
Crossref
Crossref
Eric Laille, Sanjay Goel, Alain C. Mita, Nashat Y. Gabrail, Kevin Kelly, Liangang Liu, Stephen Songer & Charles L. Beach. (2013) A Phase I Study in Patients with Solid or Hematologic Malignancies of the Dose Proportionality of Subcutaneous Azacitidine and Its Pharmacokinetics in Patients with Severe Renal Impairment. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34:5, pages 440-451.
Crossref
Crossref
E. Pautas, V. Siguret & I. Gouin-Thibault. (2014) Anemia del soggetto anziano. EMC - AKOS - Trattato di Medicina 16:1, pages 1-6.
Crossref
Crossref
Norbert Gattermann, Andrea Kündgen, Lenka Kellermann, Matti Zeffel, Bernadette Paessens & Ulrich Germing. (2013) The impact of age on the diagnosis and therapy of myelodysplastic syndromes: results from a retrospective multicenter analysis in Germany. European Journal of Haematology 91:6, pages 473-482.
Crossref
Crossref
Reinhard Stauder. (2012) The challenge of individualised risk assessment and therapy planning in elderly high-risk myelodysplastic syndromes (MDS) patients. Annals of Hematology 91:9, pages 1333-1343.
Crossref
Crossref
Frédéric Peyrade, Lauris Gastaud, Daniel Ré, Sandrine Pacquelet-Cheli & Antoine Thyss. (2012) Treatment decisions for elderly patients with haematological malignancies: a dilemma. The Lancet Oncology 13:8, pages e344-e352.
Crossref
Crossref
J. M. Willems, W. P. J. den Elzen, L. T. Vlasveld, R. G. J. Westendorp, J. Gussekloo, A. J. M. de Craen & G. J. Blauw. (2012) No increased mortality risk in older persons with unexplained anaemia. Age and Ageing 41:4, pages 501-506.
Crossref
Crossref
Bart Scott. (2012) Discussion. The American Journal of Medicine 125:7, pages S33-S34.
Crossref
Crossref
Roger M. Lyons. (2012) Myelodysplastic Syndromes: Therapy and Outlook. The American Journal of Medicine 125:7, pages S18-S23.
Crossref
Crossref
Awais M. Khan. (2012) Why Are Myelodysplastic Syndromes Unrecognized and Underdiagnosed?: A Primary Care Perspective. The American Journal of Medicine 125:7, pages S15-S17.
Crossref
Crossref
James M. Foran & Jamile M. Shammo. (2012) Clinical Presentation, Diagnosis, and Prognosis of Myelodysplastic Syndromes. The American Journal of Medicine 125:7, pages S6-S13.
Crossref
Crossref
Pasquale Niscola, Andrea Tendas, Marco Giovannini, Luca Cupelli, Malgorzata Monika Trawinska, Massimiliano Palombi, Laura Scaramucci, Gregorio Antonio Brunetti, Alessio Perrotti, Benedetta Neri, Fabio Efficace, Claudio Cartoni, Paolo de Fabritiis & Franco Mandelli. (2012) Transfusions at home in patients with myelodysplastic syndromes. Leukemia Research 36:6, pages 684-688.
Crossref
Crossref
Mary Laudon Thomas. (2012) The Impact of Myelodysplastic Syndromes on Quality of Life: Lessons Learned from 70 Voices. The Journal of Supportive Oncology 10:1, pages 37-44.
Crossref
Crossref
Jean Klastersky, Andrea Gombos, Aspasia Georgala & Ahmad Awada. (2011) Prevention of neutropenia-related events in elderly patients with hematological cancer. Aging Health 7:6, pages 829-842.
Crossref
Crossref
Rodolfo E. Bordoni, Bruce A. Feinberg, James W. Gilmore, Sally Haislip, James H. Jackson, Eileen Farrelly, Edward Kim & Deborah Buchner. (2011) Hematologic Outcomes of Myelodysplastic Syndromes Treatment With Hypomethylating Agents in Community Practice. Clinical Lymphoma Myeloma and Leukemia 11:4, pages 350-354.
Crossref
Crossref